Mechanism of Action: Protein Synthesis Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Protein Synthesis Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Encube | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211297-001 | Oct 13, 2020 | AB | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Alembic | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212188-001 | Oct 21, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Cipla | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212224-001 | Feb 9, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Padagis Us | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 211848-001 | Oct 13, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Taro | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212215-001 | May 7, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Amneal | TAVABOROLE | tavaborole | SOLUTION;TOPICAL | 212256-001 | Nov 25, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
